Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Pertuzumab> ?p ?o }
Showing triples 1 to 79 of
79
with 100 triples per page.
- Pertuzumab abstract "Pertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody marketed by Genentech for the treatment of HER2-positive breast cancer, in combination with trastuzumab and docetaxel. The first of its class in a line of agents called "HER dimerization inhibitors". By binding to HER2, it inhibits the dimerization of HER2 with other HER receptors, which is hypothesized to result in slowed tumor growth. Pertuzumab received US FDA approval for the treatment of HER2-positive metastatic breast cancer on June 8, 2012. Pertuzumab was developed at Genentech and is now owned by Roche which acquired Genentech in 2009.".
- Pertuzumab atcPrefix "L01".
- Pertuzumab atcSuffix "XC13".
- Pertuzumab casNumber "380610-27-5".
- Pertuzumab fdaUniiCode "K16AIQ8CTM".
- Pertuzumab thumbnail Pertuzumab-HER2_complex_1S78.png?width=300.
- Pertuzumab wikiPageExternalLink www.perjeta.com.
- Pertuzumab wikiPageID "9003588".
- Pertuzumab wikiPageLength "11053".
- Pertuzumab wikiPageOutDegree "15".
- Pertuzumab wikiPageRevisionID "664658428".
- Pertuzumab wikiPageWikiLink Cancer.
- Pertuzumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Pertuzumab wikiPageWikiLink Docetaxel.
- Pertuzumab wikiPageWikiLink Genentech.
- Pertuzumab wikiPageWikiLink HER2.
- Pertuzumab wikiPageWikiLink neu.
- Pertuzumab wikiPageWikiLink Hoffmann-La_Roche.
- Pertuzumab wikiPageWikiLink Monoclonal_antibody.
- Pertuzumab wikiPageWikiLink Progression-free_survival.
- Pertuzumab wikiPageWikiLink Protein_dimer.
- Pertuzumab wikiPageWikiLink Trastuzumab.
- Pertuzumab wikiPageWikiLinkText "Omnitarg".
- Pertuzumab wikiPageWikiLinkText "PERJETA".
- Pertuzumab wikiPageWikiLinkText "Pertuzumab".
- Pertuzumab wikiPageWikiLinkText "pertuzumab".
- Pertuzumab atcPrefix "L01".
- Pertuzumab atcSuffix "XC13".
- Pertuzumab caption "The structure of HER2 and pertuzumab".
- Pertuzumab casNumber "380610".
- Pertuzumab chembl "2007641".
- Pertuzumab chemspiderid "NA".
- Pertuzumab hasPhotoCollection Pertuzumab.
- Pertuzumab kegg "D05446".
- Pertuzumab legalUs "Rx-only".
- Pertuzumab licenceUs "Pertuzumab".
- Pertuzumab mabType "mab".
- Pertuzumab pregnancyUs "D".
- Pertuzumab routesOfAdministration "Intravenous".
- Pertuzumab source "zu/o".
- Pertuzumab target HER2.
- Pertuzumab target neu.
- Pertuzumab tradename "Perjeta; Omnitarg".
- Pertuzumab type "mab".
- Pertuzumab unii "K16AIQ8CTM".
- Pertuzumab verifiedfields "changed".
- Pertuzumab verifiedrevid "464199526".
- Pertuzumab watchedfields "changed".
- Pertuzumab wikiPageUsesTemplate Template:Drugbox.
- Pertuzumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Pertuzumab wikiPageUsesTemplate Template:Reflist.
- Pertuzumab subject Category:Monoclonal_antibodies.
- Pertuzumab hypernym Antibody.
- Pertuzumab type Article.
- Pertuzumab type ChemicalSubstance.
- Pertuzumab type Drug.
- Pertuzumab type Antibody.
- Pertuzumab type Article.
- Pertuzumab type Chemical.
- Pertuzumab type ChemicalObject.
- Pertuzumab type Thing.
- Pertuzumab type Q8386.
- Pertuzumab comment "Pertuzumab (also called 2C4, trade name Perjeta) is a monoclonal antibody marketed by Genentech for the treatment of HER2-positive breast cancer, in combination with trastuzumab and docetaxel. The first of its class in a line of agents called "HER dimerization inhibitors". By binding to HER2, it inhibits the dimerization of HER2 with other HER receptors, which is hypothesized to result in slowed tumor growth.".
- Pertuzumab label "Pertuzumab".
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab sameAs ペルツズマブ.
- Pertuzumab sameAs Pertuzumabe.
- Pertuzumab sameAs m.027t1rb.
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab sameAs Pertuzumab.
- Pertuzumab sameAs Q1998021.
- Pertuzumab sameAs Q1998021.
- Pertuzumab sameAs 帕妥珠单抗.
- Pertuzumab wasDerivedFrom Pertuzumab?oldid=664658428.
- Pertuzumab depiction Pertuzumab-HER2_complex_1S78.png.
- Pertuzumab isPrimaryTopicOf Pertuzumab.
